Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Hyperfine ( (HYPR) ) just unveiled an announcement.
In the fourth quarter of 2024, Hyperfine achieved several milestones to support its growth in 2025. These accomplishments include receiving accreditation for its ultra-low-field MRI technology from the Intersocietal Accreditation Commission, obtaining CE approval for its AI-powered brain imaging software, and expanding global market reach with new distribution partnerships. The company also presented scientific abstracts and data at notable conferences, highlighting the potential value of its Swoop® system in patient management and appointed new executives to drive its adoption in hospital and neurology office settings.
More about Hyperfine
Hyperfine operates in the medical imaging industry, focusing on AI-powered portable MRI technology, particularly the Swoop® system. The company aims to disrupt brain imaging with its ultra-low-field MRI technology, making it accessible and affordable in various healthcare settings globally.
YTD Price Performance: 70.41%
Average Trading Volume: 176,980
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $118.2M
See more data about HYPR stock on TipRanks’ Stock Analysis page.
